Delivery Timeline: October 2027

Location: Lebanon, Indiana

Network: API

The LP2 project is the second major manufacturing facility on Lilly’s Lebanon campus, expanding our capability to produce next-generation medicines. The site brings new capacity for peptide, small-molecule, and oligonucleotide therapies, supported by multiple manufacturing buildings, advanced utilities, and major foundational infrastructure. LP2 strengthens the resilience of our network and positions Lebanon as a key hub for delivering the pipeline of tomorrow.